IRB Barcelona logo

Research. Discover. Cure.

Mouse Scroll
Home IRB

Latest scientific news

See more newsSee selected publications
Dr. Eduard Batlle receives an ERC Advanced Grant to block metastatic colorectal cancer’s ability to evade treatment

The European grant, worth €2.5M, will allow the recruitment of research personnel and the deployment of advanced tumour analysis technologies.

More information
IRB Barcelona coordinates MD4SB, a project to boost dynamic description in structural biology

The project brings together 25 partners across 8 countries and incorporates Almirall, Sanofi, and other pharmaceutical companies to provide feedback and evaluate the practical usefulness of the platform in industrial settings.

More information
Shilpa Biocare invests in Gate2Brain to advance an innovative therapeutic candidate for brain cancer

Gate2Brain, an IRB Barcelona spin-off, signs a strategic partnership with Shilpa Biocare, including a €7 million investment for a 30.4% equity stake in the company.
 

More information
Ona Therapeutics raises $86.6 M Series B to advance first-in-class ADCs into clinical development

The financing supports Ona Therapeutics, an IRB Barcelona and ICREA spin-off, in its transition to a clinical-stage company.

More information
HelixAI: New spin-off from IRB Barcelona, ICREA, and UPC to transform biomedical data into clinical insight using AI

HelixAI, the ninth spin-off for IRB Barcelona, integrates multi-omic data to drive both biomedical research and clinical practice.

More information

Upcoming Events

irbbarcelona events
Upcoming Events
See more events
IRB Barcelona BioMed Seminars
Plasticity in human gut & cancer
IRB Barcelona BioMed Workshops
BIST Career Week 2026
See more events